Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04169347
Title FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Criterium, Inc.
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + Panitumumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Recruiting Tucson Arizona 85724 United States Details
Yale Cancer Center Recruiting New Haven Connecticut 06520 United States Details
Mount Sinai Comprehensive Cancer Center Recruiting Miami Beach Florida 33140 United States Details
University of Iowa Hospitals & Clinics Recruiting Iowa City Iowa 52242 United States Details
Kansas University Cancer Center Recruiting Westwood Kansas 66205 United States Details
Rutgers Cancer Institute of New Jersey Recruiting New Brunswick New Jersey 08903 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health Recruiting New York New York 10016 United States Details
Swedish Cancer Institute Recruiting Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field